BALOXAVIR MARBOXIL vs BASILIXIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BALOXAVIR MARBOXIL vs BASILIXIMAB: Safety Overview
| Metric | BALOXAVIR MARBOXIL | BASILIXIMAB |
|---|---|---|
| Total FAERS Reports | 2,010 | 6,817 |
| Deaths Reported | 120 | 1,507 |
| Death Rate | 6.0% | 22.1% |
| Hospitalizations | 378 | 2,802 |
| Average Patient Age | 37.8 yrs | 44.2 yrs |
| % Female Patients | 53.8% | 35.9% |
| FDA Approval Date | Mar 18, 2021 | N/A |
| Manufacturer | Genentech, Inc. | Novartis Pharmaceuticals Corporation |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Discontinued | Prescription |